Brcarib 150 mg Tablet 30's belongs to a group of medicines known as 'anti-cancer' drugs used to treat various cancers, including Ovarian, breast, pancreatic, and prostate. Cancer is a condition where cells in a specific body part grow and reproduce uncontrollably. The cancerous cells can attack and destroy surrounding healthy tissue, including organs.

Brcarib 150 mg Tablet 30's contains Olaparib, a targeted drug called a PARP inhibitor. PARP (polyadenosine 5’-diphosphoribose polymerase) is a protein that helps damaged cells repair themselves. Olaparib stops PARP working. Some cancer cells rely on PARP to keep their DNA healthy. So, the cancer cells die when Olaparib stops PARP from repairing DNA damage.

Use this medicine as directed by your doctor. You may sometimes experience shortness of breath (dyspnoea), feeling very tired, pale skin or fast heartbeat, anaemia, feeling sick (nausea), being sick (vomiting), indigestion or heartburn (dyspepsia), loss of appetite, headache, changes in taste of foods (dysgeusia), feeling dizzy, cough and diarrhoea. Most of these side effects may gradually resolve over time. However, if the side effects persist or worsen, consult your doctor.

To treat your condition effectually, continue taking Brcarib 150 mg Tablet 30's for as long as your doctor has prescribed. Do not stop using the Brcarib 150 mg Tablet 30's midway. Talk to your doctor before taking Brcarib 150 mg Tablet 30's if you have severe allergic reactions to Brcarib 150 mg Tablet 30's or other medicines or suffer from severe infections, renal dysfunction, hepatic disorders and blood cell counts are too low. Avoid taking Brcarib 150 mg Tablet 30's if you are pregnant or breastfeeding because this Brcarib 150 mg Tablet 30's can cause harmful effects on the unborn baby. Both women and men using this Brcarib 150 mg Tablet 30's should use birth control to avoid pregnancy. While on Brcarib 150 mg Tablet 30's treatment, you should avoid eating grapefruit, Seville oranges or consuming grapefruit juice since it can affect how the medicine works.

Brcarib 150 mg Tablet 30's contains Olaparib, a targeted drug called a PARP inhibitor. PARP is a protein that helps damaged cells to repair themselves. Olaparib stops PARP working. Some cancer cells rely on PARP to keep their DNA healthy. So, the cancer cells die when Olaparib stops PARP from repairing DNA damage. Thus, it treats various cancers, including Ovarian, breast, pancreatic, and prostate. It can be used alone or with other chemotherapy drugs, depending on your type of cancer.

Always take this medicine exactly as your doctor or healthcare professional has told you. To treat your condition effectually, continue taking Brcarib 150 mg Tablet 30's for as long as your doctor has prescribed. Do not stop Brcarib 150 mg Tablet 30's midway. Talk to your doctor before taking Brcarib 150 mg Tablet 30's if you have severe allergic reactions to Brcarib 150 mg Tablet 30's or other medicines or suffer from any medical illness. Avoid taking Brcarib 150 mg Tablet 30's if you are pregnant or breastfeeding because this Brcarib 150 mg Tablet 30's can cause harmful effects on the unborn baby. Both women and men using this Brcarib 150 mg Tablet 30's should use birth control to avoid pregnancy. Do not start Brcarib 150 mg Tablet 30's unless patients have recovered from haematological damage induced by previous chemotherapy (Grade 1). Check full blood count for cytopenia at baseline and monthly afterwards for clinically significant changes during treatment. For persistent haematological toxicity, discontinue Brcarib 150 mg Tablet 30's and monitor blood count weekly until recovery. Do not receive any immunization or vaccination without your doctor's approval while taking the Brcarib 150 mg Tablet 30's.

• Pregnancy testing is recommended for females of reproductive potential prior to initiating treatment with Brcarib 150 mg Tablet 30's.
• Brcarib 150 mg Tablet 30's should be taken under strict medical supervision. The doctor will regularly monitor your condition while taking Brcarib 150 mg Tablet 30's.
• Monitor complete blood count for cytopenia at baseline and monthly for clinically significant changes during treatment.
• Your doctor may get routine blood tests done to monitor your liver function, electrolyte levels, and blood cell count in your blood.
• Peripheral blood counts should be frequently monitored during Brcarib 150 mg Tablet 30's treatment and, when appropriate, until recovery is achieved.
• Do not donate sperm during treatment with Brcarib 150 mg Tablet 30's for three months after your last dose.